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Estrogen receptor b (ERb) plays a unique role in endometriotic tissue, where it interacts with the cytoplasmic apoptotic machinery and inflammasome complex to prevent TNF-a-induced cell death and enhance adhesion and proliferative activities of endometriotic tissues. This non-genomic action of ERb has a predominant role in endometriosis progression.
INTRODUCTION
Endometriosis is a medical condition in which endometrial cells are deposited and grow outside the uterine cavity (Bulun, 2009; Giudice, 2010) . Severe symptoms of endometriosis are typically observed in 6%-10% of reproductive-aged women (Simoens et al., 2007) . Among patients with endometriosis, approximately 50% have major pelvic pain, and 40%-50% have fertility problems (Eskenazi and Warner, 1997; Ozkan et al., 2008) . In these patients, endometriosis-associated symptoms negatively impact their health and quality of life (Moradi et al., 2014) .
To improve the efficiency of endometriosis therapies, it is important to dissect the unique molecular properties of endometriotic tissues compared with normal endometria. Previous studies identified several endocrine properties associated with endometriotic tissues. Altered estrogenic signaling pathways have been reported in endometriosis pathogenesis (Bulun, 2009) . Endometriotic lesions have been reported to contain higher 17b-estradiol levels than normal endometria due to the elevated expression of 17b-hydroxysteroid dehydrogenase-1 and aromatase genes compared with normal endometria (Acié n et al., 2007; Delvoux et al., 2009 ). These higher levels of local 17b-estradiol could play a role in the proliferation of endometriotic tissues (Zhang et al., 2010) . This increased 17b-estradiol binds and activates estrogen receptors (ERs) in endometriotic tissues to stimulate estrogen-dependent growth. There are two different forms of the ER, usually referred to as a and b, each encoded by a different gene, ESR1 and ESR2, respectively. Prior studies with ERa À/À , ERb À/À mouse models and selective estrogen receptor modulators revealed essential roles of both ERa and ERb in mouse ectopic lesion development (Burney, 2013; Zhao et al., 2015) . However, each ER isoform has a unique expression pattern between endometriotic tissues and normal endometrium. In the case of ERa, it is controversial whether ERa has an endometriotic tissue-specific pattern (Han and O'Malley, 2014) . In contrast to ERa, however, the mRNA level of ERb is significantly higher in endometriotic tissues than in normal uterine endometrium (Bulun et al., 2012) . Aberrant ERb levels in endometriotic tissues have been associated with a distinct epigenomic profile in the ERb genomic locus: a hypomethylated promoter of the ERb gene was detected in endometriotic tissues compared with normal endometria and correlates with increased ERb mRNA levels (Xue et al., 2007) . What is the role of ER isoforms in the pathogenesis of endometriosis? Unfortunately, the detailed molecular mechanism regarding specific contribution of each ER isoform in the endometriosis progression is not clearly elucidated yet. Only partial information is available. For examples, ERa À/À mouse with endometriosis revealed that the ESR1 gene is required for attachment, inflammation, and proliferation of ectopic lesions (Burns et al., 2012) . ERb directly induces Ras-like estrogen-regulated growth-inhibitor gene expression in an estrogen-dependent manner to enhance the proliferative activity of endometriotic tissues (Monsivais et al., 2014) . In addition, ERb directly binds to the ERa promoter region to repress ERa gene expression, which can lead to a state of progesterone resistance in the endometriotic tissues by suppressing ERa-mediated progesterone receptor (PR) expression in endometriotic tissues (Bulun et al., 2012) . However, we believe the complete repertoire of ERb functions to be more complicated because greatly elevated levels of ERb exist in both nuclear and cytoplasmic locations in endometriotic tissues (Cheng et al., 2011) . We believed a more detailed investigation should be carried out to fully understand the mechanisms of ERb action in endometriosis progression. We propose a cytoplasmic ERB protein network that, in addition to its genomic functions, promotes endometriosis pathogenesis in a non-genomic manner. Together with our previously observed SRC-1 coactivator isoform, these two drivers of endometriotic disease cooperate to render endometriosis a therapeutically complex disease.
RESULTS

Mouse Endometriotic Tissues Have Elevated ERb Levels Similar to Those in Human Endometriotic Cells
Human endometriotic cells isolated from endometriosis patients have higher levels of ERb, but not ERa, than do normal human endometrial cells (Han et al., 2012) . Consistent with human endometriotic cells, both eutopic and ectopic endometria from mice with endometriosis also had markedly higher ERb levels compared with the uteri of sham-treated mice (Figures 1A and 1B) . In contrast to ERb, however, the levels of ERa did not differ in eutopic endometria but were reduced in ectopic lesions compared with shamtreated uteri ( Figures 1A and 1B) . Levels of PR were reduced in both ectopic lesions and eutopic endometria of mice with endometriosis compared with the uteri of sham-treated mice (Figures 1A and 1B) . Immunohistochemistry (IHC) using an ERb antibody (validation of its specificity in Figure 4B ) revealed elevated ERb levels in the epithelial and stromal compartments of both ectopic lesions and eutopic endometria compared with those compartments in normal endometrium ( Figure 1C) . Therefore, the ERb levels are elevated in endometriotic tissues of mice with endometriosis, similar to the levels observed in human endometriotic cells.
Endometriotic Tissues Have Enhanced ERb Activity Compared with Normal Endometria
To determine ERb activity in endometriotic tissues in vivo, we generated an ERb activity indicator (ERBAI) mouse containing a modified ERb bacterial artificial chromosome clone that has a Gal4 DNA-binding domain (DBD) instead of its own DBD and a hrGFP reporter controlled by the Gal4-upstream activating sequence (UAS) according to our prior protocol (Han et al., 2009) ( Figures 2A and S1 ). Therefore, Gal4-ERb binds to Gal4-UAS, transcribing hrGFP gene expression in response to hormone. Detailed information regarding the generation and validation of the ERBAI mouse model is described in the Supplemental Information ( Figure S1 ).
To investigate potential alterations in ERb activity in endometriotic tissues during endometriosis progression, endometriosis was surgically induced using an ERBAI mouse model through autotransplantation; to monitor ERb activity, the hrGFP levels were determined in ectopic and eutopic endometria of ERBAI mice with endometriosis and in the uteri of sham-treated ERBAI mice. Elevated hrGFP levels were detected in epithelial and stromal cells of ectopic and eutopic endometria compared with those found in the normal uteri of sham-treated ERBAI mice ( Figures 2B-2D ). Therefore, enhanced ERb activities were detected in the stromal and epithelial compartments of endometriotic tissues compared with normal endometria. In all panels, error bars represent ± SD. See also Figure S1 .
Enhanced ERb Activity Is Required for Ectopic Lesion Growth in Mice with Endometriosis Although enhanced ERb activity was detected in endometriotic tissues, it was not clear whether the enhanced ERb activity was required for ectopic lesion growth. Therefore, PHTPP, an ERb-selective antagonist (Compton et al., 2004) , was employed to address it. Ectopic lesions were surgically developed in ovariectomized C57BL/6J mice containing an Estradiol (E2) pellet. On the 21 st day after endometriosis induction, PHTPP or vehicle was administered to endometriosis-induced mice ( Figure  S2A ). Compared with vehicle treatment, PHTPP treatment significantly suppressed ectopic lesion growth in mice with endometriosis ( Figure 3A ). For the stimulation of ectopic lesion growth, endometriotic tissues recruit immune cells (CD163-positive monocyte/macrophage cells) to enhance immune cell-mediated cytokine signaling ( Figure S2B, arrowhead) . However, PHTPP-treated ectopic lesions did not recruit immune cells compared with vehicle-treated ectopic lesions ( Figure S2B ). In addition, PHTPP treatment clearly diminished ERb activity in the epithelial and stromal compartments of ectopic lesions and the eutopic endometrium of mice with endometriosis compared with vehicle ( Figures 3B and 3C ). Collectively, PHTPP inhibits ERb activity, which leads to endometriotic lesion growth in mice with endometriosis.
Anti-apoptosis signaling and the acceleration of proliferation are typical molecular properties associated with the survival of endometriotic tissues (Pellegrini et al., 2012; Salmassi et al., 2011) . Because endometriotic tissues consist of epithelial and stromal compartments, signaling communication between these compartments plays an essential role in endometriotic lesion progression (Kim et al., 2013) . Therefore, functional defects involving hyperproliferation and anti-apoptosis signaling in either compartment in endometriotic tissues should impair cellular processes in the other compartment, ultimately leading to the suppression of ectopic lesion growth. PHTPP treatment, compared with vehicle treatment, reduced proliferative activity as determined by Ki-67 in the epithelial, but not stromal, compartments of ectopic lesions in C57BL/6J mice with endometriosis ( Figure 3D ). In the case of apoptosis signaling as determined by cleaved caspase 8 levels, PHTPP treatment significantly enhanced apoptotic signaling in both the epithelial and stromal compartments of ectopic lesions of C57BL/6J mice with endometriosis compared with vehicle treatment ( Figure 3E ). In addition to ectopic lesions, PHTPP suppressed proliferation and anti-apoptosis signaling in the epithelium and inhibited proliferation in stromal cells in the eutopic endometria of mice with endometriosis ( Figures 3F and 3G ).
In addition to ERb, PHTPP can inhibit ERa activity in vivo, although its effects on ERa are minimal (Compton et al., 2004) . To address this issue, the levels of mouse uterine ERa direct target genes (such as PR, CDKN1A, and ERRFI1) were examined in ovariectomized mice upon E2 and/or PHTPP treatment. PHTPP partly reduced the expression of direct ERa target genes stimulated by E2 ( Figures S2C-S2E ). Interestingly, a female mouse fertility assay revealed that PHTPP did not reduce reproductive activity in female mice, whereas an ERa-selective antagonist, MPP dihydrochloride, significantly reduced the fertility of female mice compared with vehicle treatment ( Figure S2F ). Therefore, PHTPP does not disrupt the fertility of female mice, though it partly suppresses uterine ERa activity. In contrast to the effects of PHTPP, ERB-041 (ERb-specific agonist) treatment enhanced the mouse ectopic lesion growth compared with vehicle ( Figure S2G ).
To address the effects of ERB-041 and PHTPP in human endometriotic lesion growth, we employed two types of human endometrial cells: EMosis-CC/TERT cells, which are immortalized human endometriotic epithelial cells isolated from ovarian endometriomas (Bono et al., 2012) , and immortalized human endometrial stromal cells (iHESCs) (Krikun et al., 2004) . For simplification, EMosis-CC/TERT cells are called immortalized human endometriotic epithelial cells (iHEECs) hereafter. For non-invasive bioluminescence imaging analyses of ectopic lesions in SCID mice, luciferase reporters expressing iHEECs (iHEECs/Luc) and iHESCs (iHESCs/Luc) were generated using a lentiviral expression system. To induce endometriosis, a mixture of epithelial and stromal cells (iHEECs/Luc plus iHESCs/Luc) was injected into ovariectomized SCID mice with an E2 pellet. On the 21 st day after endometriosis induction, endometriosisinduced SCID mice were treated with ERB-041 or PHTPP for another 21 days ( Figure S2A ). Ectopic lesion image analyses revealed that ERB-041 treatment stimulated human ectopic lesion growth, whereas PHTPP treatment decreased ectopic lesion growth in SCID mice ( Figure S2H ). Moreover, ERBAI mice with endometriosis also revealed that ERB-041 enhanced ERb activity in ectopic lesions compared with vehicle treatment (Figure S2I) . Collectively, enhanced ERb activity is required for the pathogenesis of endometriosis (Table 1) .
Loss of ERb Function Suppresses Ectopic Lesion Growth in Mice with Endometriosis
To directly investigate the loss of ERb function in the pathogenesis of endometriosis, endometriosis was surgically induced via the auto-transplantation of uterine tissue using ERb À/À (Krege et al., 1998) and wild-type (WT) mice. The sizes of the ERb À/À ectopic lesions were reduced significantly compared with WT ectopic lesions ( Figure 4A ). IHC using an ERb antibody (Saji et al., 2000) validated the fact that ERb À/À ectopic lesions did not exhibit ERb expression compared with WT ectopic lesions ( Figure 4B ).
To investigate how loss of the ERb function impacts ectopic lesion progression, cell proliferation and apoptotic signals in each type of ectopic lesion were examined. The reduced levels of epithelial, but not stromal, proliferation were detected in ERb À/À ectopic lesions compared with WT ectopic lesions (Figure 4C and Table 1 ). In contrast to proliferation, however, loss of ERb functions significantly elevated epithelial, but not stromal, apoptosis in ERb À/À ectopic lesions ( Figure 4D and Table 1 ).
Regarding eutopic endometrium, loss of ERb function did not impair the proliferation of ERb À/À eutopic endometria compared with WT eutopic endometria during endometriosis progression ( Figure 4E and Table 1 ). However, apoptosis signaling was elevated in both compartments of the eutopic endometrium in the absence of the ERb gene compared with WT eutopic endometrium ( Figure 4F and Table 1 ).
Gain of ERb Function Stimulates Ectopic Lesion Growth in Mice with Endometriosis
To mimic ERb elevation in human and mouse endometriotic tissues, an endometrium-specific ERb-overexpressing mouse model was generated and validated ( Figure S3 ). For simplification, ROSA LSL:ERb/+ monogenic mice, which do not express exogenous ERb, and endometrium-specific ERb-overexpressing (ROSA LSL:ERb/+ :PR CRE/+ ) bigenic mice are hereafter referred to as control and ERb:OE mice, respectively ( Figure S3A ).
To determine whether endometrium-specific ERb overexpression impacts ectopic lesion growth, endometriosis was surgically induced by auto-transplantation using ovariectomized control and ERb:OE mice containing E2 pellets. ERb:OE ectopic lesions had much larger volumes than did control ectopic lesions in mice with endometriosis ( Figure 5A ). Exogenous Flag/Myctagged ERb expression and elevated levels of total ERb were determined in ERb:OE ectopic lesions compared with control ectopic lesions ( Figures 5B and S3) . Thus, elevated ERb levels in ectopic lesions enhanced ectopic lesion growth. The overexpression of nuclear receptors can induce ligand-independent effects (Weigel and Zhang, 1998) . However, neither control nor ERb:OE endometrial tissue fragments successfully developed into ectopic lesions in ovariectomized mice without the administration of an E2 pellet ( Figure S3F ). Therefore, gain-of-ERbfunction-mediated stimulation of ectopic lesion growth is an estrogen-dependent process.
The proliferative activity was significantly elevated in both the epithelial and stromal compartments of ERb:OE ectopic lesions compared with control ectopic lesions ( Figure 5C and Table 1 ). However, apoptosis was significantly reduced in both the epithelial and stromal compartments of ERb:OE ectopic lesions compared with control lesions ( Figure 5D and Table 1 ).
In addition to ectopic lesions, both the epithelial and stromal compartments of the ERb:OE eutopic endometrium demonstrated enhanced proliferative activity compared with control eutopic endometrium ( Figure 5E and Table 1 ). However, no alteration in apoptosis signaling was detected in ERb:OE eutopic endometrium compared with control eutopic endometrium (Figure 5F and Table 1 ). Thus, the eutopic endometria of endometriosis patients appear primarily to be in a hyperproliferative state due to elevated ERb levels. Notably, breeding trials designed to assess mating success revealed that ERb:OE mice were infertile compared with control mice ( Figure S3G ). Moreover, ERb-overexpressing iHESCs lose their decidualization response because, as compared with parental iHESCs, the induction of decidual cell marker genes, such as insulin-like growth factorbinding protein 1 and prolactin, was significantly reduced upon estradiol-medroxyprogesterone-cAMP treatment ( Figures 5G-5I ). Therefore, endometriosis-associated ERb overexpression in eutopic endometrium might impair the decidualization process in women with endometriosis, leading to infertility.
ERb Interacts with the Cytoplasmic Apoptosis and Inflammasome Machinery in Ectopic Lesions to Enhance Ectopic Lesion Survival
To further dissect the molecular mechanisms of ERb in endometriosis progression, Flag-tagged ERb-containing protein complexes were immunoprecipitated (IPed) from the eutopic endometria of ERb:OE mice with endometriosis using a Flag antibody. In IP/Mass analyses, a primary consideration is to separate out proteins that non-specifically interact with beads from the list of proteins that are associated with the target protein.
For this purpose, we employed control mice that had the same genetic background as ERb:OE mice and had extremely low levels of Flag-tagged exogenous ERb compared with ERb:OE mice ( Figure 6A ). Therefore, proteins co-IPed with the Flag antibody from endometriotic tissues of control mice are considered as non-specific bead-binding proteins. To specifically identify ERb-interacting proteins, proteins IPed from the eutopic endometria of control mice were removed from the proteins that IPed from the eutopic endometria of ERb:OE mice. Gene Ontology analyses with endometriotic tissue-specific ERb-interacting proteins revealed that large numbers of proteins involved in inflammation and apoptosis signaling were specifically co-IPed with ERb from ERb:OE eutopic endometrium ( Figures  S4A and S4B ). To validate these interactions in ectopic lesions, the ERb complex was isolated from control and ERb:OE ectopic lesions using a Flag antibody, and ERb-interacting proteins were analyzed further by western blot analyses ( Figure 6A ). Western blot analyses revealed that only a very weak Flag-ERb signal was detected in control ectopic lesions that developed in ROSA LSL:ERb/+ monogenic mice; this small amount is likely attributable to the leaky expression of exogenous ERb in the ROSA LSL:ERb/+ monogenic mouse ( Figure 6A ).
Apoptosis signal-regulating kinase 1 (ASK-1) was found to interact prominently with ERb in ectopic lesions ( Figure 6A ). ASK-1 is a component of tumor necrosis factor alpha (TNF-a)-induced apoptosis complex I, and its activation is required for TNF-a-induced apoptosis in multiple cell types (Tobiume et al., 2001) . In addition to ASK-1, serine/threonine kinase receptorassociated protein (STRAP) and 14-3-3 were also specifically co-IPed with ERb from the ERb:OE ectopic lesions, but not from control ectopic lesions ( Figure 6A ). To prevent TNFa-induced apoptosis, STRAP and 14-3-3 proteins interact with ASK-1 to disrupt associations between TNF receptor-associated factor 2 (TRAF2) and ASK-1 upon TNF-a stimulation (Hatai et al., 2000) . These data imply that ERb may induce ASK-1/ STRAP/14-3-3 complex formation to prevent the activation of TNF-a/ASK-1-mediated apoptosis in endometriotic tissues. To validate this hypothesis, the levels of ASK-1 phosphorylation at Thr845 were determined for each type of ectopic lesion because ASK-1 phosphorylation at Thr845 is associated with ASK-1 activation to enhance TNF-a-induced apoptosis (Tobiume et al., 2002) . The phospho-Thr845 ASK-1 levels were significantly reduced in ERb:OE ectopic lesions compared with control ectopic lesions without alternation of total ASK-1 levels ( Figures  6B-6D ). In contrast, the levels of total ASK-1 and phospho-ASK-1 were significantly elevated in ERb À/À ectopic lesions compared with WT ectopic lesions ( Figures S5A-S5C ). Collectively, ERb induced ASK-1/STRAP/14-3-3 complex formation to prevent ASK-1 activation in ectopic lesions, thereby promoting ectopic lesion survival. TNF-a-induced ASK-1 activation also increases mitochondrial cytochrome c levels to activate caspase 9 (Hatai et al., 2000) . The cytochrome c levels in ERb:OE ectopic lesions were significantly lower than those in control ectopic lesions ( Figure 6E) . Therefore, the gain of ERb function prevented the TNF-a/ASK-1/cytochrome c signaling pathway in ectopic lesions to promote lesion survival. After the initiation of TNF-a-induced apoptosis by apoptosis complex I, the tumor necrosis factor receptor (TNFR) 1-associated death domain (TRADD) protein, a component of complex I, is shuttled from TNFR to the cytoplasm and then interacts with the Fas-associated via death domain (FADD) protein and caspase 8 to generate apoptosis complex II to amplify TNFa-induced apoptosis (Micheau and Tschopp, 2003) . The endometriotic 70 kDa SRC-1 isoform also interacts with caspase 8 to inhibit caspase 8 activation in ectopic lesions to promote their survival (Han et al., 2012) . Interestingly, we also found that ERb interacted with caspase 8 and this SRC-1 isoform in ectopic lesions ( Figures 6A and S4C) . Moreover, ERb:OE ectopic lesions contained significantly reduced levels of cleaved caspase 8 compared with control ectopic lesions ( Figure 5D ). Therefore, we suggest that ERb also interacts with caspase 8 along with the SRC-1 isoform; this combined interaction strongly inhibits caspase 8 activation in ectopic lesions to effectively prevent activation of TNF-a-induced apoptosis complex II in ectopic lesions. However, this SRC-1 isoform/ERb/caspase 8 complex did not interact with components of TNF-a-induced apoptosis complex I and the apoptosome in ectopic lesions ( Figure S4D ).
To validate synergism between the SRC-1 isoform and ERb for the progression of endometriosis, a combination of Gossypol that reduces the transcriptional activity and stability of SRC-1 (Wang et al., 2011) and PHTPP was employed to suppress ectopic lesion growth in mice with endometriosis. This combination of Gossypol and PHTPP treatment significantly reduced ectopic lesion growth compared with individual treatments (Figures 6F and 6G) . Therefore, cooperative interactions between the ERb and SRC-1 isoforms effectively appear to drive the pathogenesis of endometriosis.
The cytochrome c effectively induces the formation of the apoptosome, which consists of caspase 9 and apoptotic peptidase-activating factor 1 (APAF-1), to activate caspase 9 (Bratton and Salvesen, 2010) . In ERb:OE ectopic lesions, the interaction of caspase 9 and APAF-1 was not detected (Figures 6H and  S5D ). The cleaved caspase 9 levels were significantly reduced in ERb:OE ectopic lesions compared with those in control ectopic lesions ( Figure 6I ). In ERb À/À ectopic lesions, however, the interaction of caspase 9 and APAF-1 was detected (Figure S5D ). These data suggest that ERb prevented TNFa-induced apoptosome formation in endometriotic cells by disrupting the interaction of caspase 9 and APAF-1 through a competitive ERb interaction with caspase 9. Collectively, ERb synergistically inhibited the activation of apoptosis complex I and complex II and apoptosome formation in ectopic lesions to effectively prevent TNF-a-induced apoptosis in endometriotic tissues for ectopic lesions survival. Caspase 1 and the NLR family pyrin domain-containing 3 (NALP3) were also co-IPed with ERb from ERb:OE ectopic lesions ( Figures 6H and S4B ). Both caspase 1 and NALP3 are components of the inflammasome, which is involved in the maturation of IL-1b formation from pro-IL-1b (Willingham et al., 2009) . Interestingly, the NALP3-mediated inflammasome has an essential role in endometriosis progression because NALP3 À/À ectopic lesion volume was significantly reduced compared with WT ectopic lesions of mice with endometriosis ( Figure 6J ). IL-1b is a key cytokine involved in both the adhesion and proliferation of endometrial cells (Cao et al., 2005; Sillem et al., 1999) . ERb:OE ectopic lesions had higher IL-1b levels than control ectopic lesions because cleaved caspase 1 levels were highly elevated in ERb:OE ectopic lesions compared with controls ( Figures 6K and 6L) . However, cleaved caspase 1 and IL-1b levels were reduced in ERb À/À ectopic lesions compared with WT lesions of mice with endometriosis ( Figure S5A ). Therefore, the combinational interactions of ERb with caspase 1 and NALP3, the activation of caspase 1, and the elevation of IL-1b levels in ectopic lesions supported our conclusion that ERb also enhances inflammasome activity in ectopic lesions for their survival. This Flag-ERb-interacting protein network may not accurately recapitulate the endogenous ERb-interacting protein network in endometriotic tissues because this network was generated by overexpressed exogenous ERb. To further address this issue, ERb complexes were isolated from ectopic lesions of C57BL/ 6J mice with endometriosis because these ectopic lesions had elevated endogenous ERb levels ( Figure 1B) . The SRC-1 isoform, caspase 8, caspase 9, caspase 1, and ASK-1 were also co-IPed with endogenous ERb from ectopic lesions similar to exogenous Flag-ERb, though the IP efficiency of ERb antibody (SC-8794, Santa Cruz) is low ( Figure S4E ). Therefore, we concluded that the overexpressed ERb complex is similar to the endogenous ERb complex in endometriotic tissues.
Gain of ERb Function Prevents TNF-a-Induced Apoptosis and Enhances Proliferation, Invasion, and Adhesion Activities of Immortalized Human Endometriotic Epithelial Cells
To investigate the functions of ERb and the ERb/SRC-1 isoform complex, iHEECs stably expressing ERb (iHEECs/ERb) and the SRC-1 isoform (iHEECs/SRC-1Iso) were generated separately and together (iHEECs/ERb/SRC-1Iso) ( Figure 7A, in bottom) . TNF-a treatment increased the levels of cleaved caspase 8 and cleaved caspase 3 in control iHEECs compared with vehicle In all panels, error bars represent ± SD. (legend continued on next page) ( Figure 7A ). However, TNF-a treatment did not enhance the levels of the above apoptosis markers in iHEECs/ERb, in iHEECs/SRC-1Iso, or in the combined iHEECs/SRC-1Iso/ERb ( Figure 7A ). Therefore, ERb and ERb/SRC-1 isoform complex effectively prevented TNF-a-induced apoptosis. The gain of ERb, but not the SRC-1 isoform, function elevated the IL-1b levels in iHEECs in the presence or absence of TNF-a treatment ( Figure 7A ). These data were also generated via the artificial overexpression of ERb. To support that gain of ERb function is not artificial, primary human endometriotic stromal cells isolated from human endometriosis patients were employed because these cells also had elevated levels of endogenous ERb compared with normal human endometrial stromal cells (Figure S4F) . Primary human endometriotic stromal cells also have elevated levels of IL-1B and anti-apoptosis signaling upon TNF-a treatment compared with normal endometrial stromal cells ( Figure S4G ). Therefore, ERb plays a critical role in antiapoptosis signaling and inflammasome activation in ectopic lesions. In addition, ERb enhanced the cell adhesion and proliferative activities of iHEECs compared with control cells in the presence of TNF-a ( Figures 7A and 7B ). Therefore, it is likely that the increased IL-1b observed with elevated ERb induces adhesion and proliferation activities of endometrial tissue fragments in the peritoneal area of endometriosis patients to initiate ectopic lesion development. In addition to IL-1b, the levels of several cytokines (such as MIP-2, IL-16, MIP-1a, MCP-5, TREM-1, and BLC) were significantly elevated in ERB:OE ectopic lesions compared with control ectopic lesions ( Figures  S6A and S6C ). Previous studies also revealed that levels of these cytokines are elevated in the peritoneal fluid of women with endometriosis (Ahn et al., 2015) . In contrast, some cytokine levels (MIG, M-CSF, TNF-a, KC, and IP-10) were reduced in ERB:OE ectopic lesions compared to control ectopic lesions ( Figures S6A and S6B) . Collectively, the gain of ERb function broadly alters the cytokine milieu in ectopic lesions in concert with promotion of endometriotic lesion growth. Consistent with SRC-1 isoform, ERb also increased the expression of EMT markers, such as Slug and Snail, and enhanced invasion activity in iHEECs ( Figures 7A and 7C) . Therefore, the increased EMT and invasion activity of ectopic lesions again occurs through the effective cooperation of the ERb and SRC-1 isoforms. However, vascular endothelial growth factor (VEGF) levels were not changed in ERb:OE ectopic lesions and iHEECs/ERb compared with their controls (Figures S6D and S6E) . Therefore, the angiogenesis of ectopic lesions is not regulated by ERb. To further support the gain of ERb function in human ectopic lesion development, iHEECs/Luc, iHEECs/ERb/Luc, and iHESCs/Luc were employed for non-invasive bioluminescence imaging analysis of ectopic lesion growth in SCID mice. To induce endometriosis, a mixture of iHESCs/Luc plus iHEECs/ERb/Luc was injected into ovariectomized SCID mice with an E2 pellet. For controls, a mixture of iHESCs/Luc and iHEECs/Luc was injected. Bioluminescence image analysis on injection day 0 revealed that similar amounts of human endometrial cells for each group were injected into recipient SCID mice ( Figure 7D ). Comparative bioluminescent analysis on the 21 st day after injection revealed that human ectopic lesions with ERb overexpression exhibited stronger bioluminescent activity compared with control ectopic lesions ( Figure 7E ). Therefore, ERb enhanced the in vivo survival rate of human endometriotic cells and promoted their development into human ectopic lesions in SCID mice.
In addition to ERb, ERa plays an essential role in the pathogenesis of endometriosis in the mouse model (Burns et al., 2012) . To determine the functional difference between ERa and ERb in endometriosis progression, iHEECs expressing Myc-tagged human ERa genes (iHEECs/ERa) were generated ( Figure S7A ). In contrast to iHEECs/ERb, however, gain of ERa function did not prevent TNF-a-induced apoptosis signaling and did not induce IL-1b expression, proliferative activity, or expression of EMT markers (Slug and Snail) and VEGF in iHEECs/ERa compared with parental iHEECs upon TNF-a treatment ( Figure S7A ).
Unlike ERb, therefore, ERa is not involved directly in the evasion of immune surveillance or in the invasion and IL-1b-mediated proliferation of ectopic lesions. For the combination of ERa and ERb, ERa did not interfere with ERb-mediated antiapoptotic activity in iHEECs upon TNF-a treatment ( Figure S7B ). In fact, ERa inhibited ERb-mediated IL-1b production (Figure S7B) . Therefore, ERa might be involved in the negative regulation of ERb-mediated inflammasome activation.
Taken together, the gain of ERb and SRC-1 isoform function in endometrial fragments generated by retrograde menstruation prevents TNF-a-induced apoptosis complex activity to evade immune surveillance. After evasion, ERb interacts with the inflammasome complex to induce IL-1b in endometrial fragments that have evaded immune surveillance to facilitate attachment to and growth at target sites ( Figure 7F ). In addition, ERb also induces EMT and invasion activity in cooperation with the SRC-1 isoform to establish endometriotic lesions ( Figure 7F ). function study revealed that ERb prevents apoptosis singling and enhances adhesion, invasion, proliferation, inflammasome activity, and inflammation signaling in ectopic lesions for their growth. The study with ERa (À/À) mice with endometriosis revealed that ERa drives proliferation, adhesion, and angiogenesis and also modulates inflammation signaling in ectopic lesions (Burns et al., 2012) . To establish endometriotic lesions, collectively, both ERa and ERb might synergistically contribute the regulation of proliferation, adhesion, and inflammation signaling in ectopic lesions. However, ERa mainly drives angiogenesis, and ERb has a predominant role in anti-apoptosis and activation of inflammasome and invasion in ectopic lesions for their survival.
DISCUSSION
Based on a retrograde menstruation model for endometriosis (Hughesdon, 1958) , endometrial tissue and erythrocytes are shed through the fallopian tubes into the peritoneal cavity during menses. In healthy women, refluxed endometrial fragments that appear during retrograde menstruation are cleared by inflammatory mediated cell-death signaling, such as caspase-1-mediated pyroptosis (Miao et al., 2011) . However, endometriosis patients have an immunity that prevents them from clearing the refluxed endometrial fragments and then potentiates the development and severity of endometriosis. For survival, endometrial tissue fragments must evade the immune surveillance system, particularly peritoneal macrophages (Nasu et al., 2009) . During the early steps of evasion from the immune surveillance system, ERb generates a cytoplasmic protein network to rapidly prevent TNF-b-mediated apoptosis by inactivating TNF-a-induced apoptosis complex I and II and the apoptosome. We believe that a key synergism exists between ERb and the SRC-1 isoform during this evasion of the immune surveillance system because the SRC-1 isoform also prevents TNF-a-induced apoptosis in ectopic lesions. Our combined observations lead us to propose that ERb and the SRC-1 isoform act cooperatively together to affect a potent anti-apoptotic state in endometriotic tissues.
The formation of the inflammasome and the activity of caspase 1 determine the balance between pathogen resolution and disease pathology. How is the inflammasome involved in the pathogenesis of endometriosis? The NALP3 gene has an essential role in endometriosis progression because NALP3 À/À mice have a defect in ectopic lesion growth under endometriosis. ERb involves in upregulation of the NALP3 inflammasome in hepatocellular carcinoma cells upon estrogen stimulation even though the interaction of ERb with NALP3 is not clearly demonstrated (Wei et al., 2015) . Here, we revealed that ERb interacts with inflammasome components and enhances inflammasome activity through the activation of caspase 1 activity. Activation of the inflammasome results in highly elevated IL-1b levels in endometriotic tissues compared with normal endometrium, and enhanced IL-1b signaling can influence the adhesion activity of endometriotic tissues and proliferative activities of human endometrial cells.
The Gain of ERb Function May Lead to Female Infertility
One of the primary symptoms associated with endometriosis is dysfunction of the normal endometrium, leading to endometriosis-associated infertility (Holoch and Lessey, 2010) . In addition to ectopic lesions, we found that eutopic endometrium demonstrated elevated levels of ERb compared with normal endometrium. We believe that ERb overexpression could increase endometriosis-associated infertility by preventing the decidualization response in the stromal compartment of eutopic endometrium. Thus, targeting ERb could have dual potential benefits in patients with endometriosis: regression of ectopic lesion growth and enhancement of fecundity of women with endometriosis.
A Combination Therapy using Antagonists of ERb and the SRC-1 Isoform Represents a Proof-of-Principle for the Next Generation of Endometriosis Therapy Inhibitors of estrogen signaling and estrogen synthesis as well as inflammatory inhibitors (COX-2 inhibitors) have been employed, given the dependence on estrogen and the inflammatory response of ectopic lesions. However, these treatments can be associated with undesirable side effects. In addition to substantiating an infertile state in young women, long-term estrogen deficiency therapies can have harmful side effects on other estrogen target tissues, such as the brain and bone (Shah et al., 1987; Vanderschueren et al., 1997) . Therefore, a greater choice of alternate therapies that more specifically target endometriotic causal modes is needed.
Our observations proposed that the targeting ERb activity should increase the specificity and efficiency of endometriosis treatment and could be an alternative combinational approach for endometriosis treatment in lieu of current estrogen-deficiency therapy. As a proof-of-principle, the application of an ERb-selective antagonist, such as PHTPP, significantly suppressed ectopic lesion growth by inhibiting ERb activity in ectopic lesions of mice with endometriosis without side effects on fertility. The minimal inhibitory effects of PHTPP against uterine ERa could also be another advantage to minimize side effects. We note that a previous study stated that ERB-041, an ERb-specific agonist, caused regression of ectopic lesion growth in an endometriosis animal model system (Harris et al., 2005) . The reason for this discrepancy could potentially be related to differential ERb expression in ectopic lesions. The expression of ERb was not detected in human ectopic lesions that developed in athymic nude mice in Harris' study. PHTPP treatment demonstrated certain differential effects in endometriotic tissues compared with ERb knockout tissues. For example, proliferation of eutopic endometrium and apoptosis in the stromal compartment of ectopic and eutopic endometrium were differentially regulated between them. This differential regulation might be attributable to the differences between pharmacological inhibition and genetic knockout.
Collectively, we propose that the SRC-1 isoform/ERb complex could be a next-generation endometriosis therapeutic target with reduced side effects compared to current endometriosis treatment because (1) ERb and the SRC-1 isoform show endometriotic tissue-specific expression but have little expression in normal endometrium; (2) both play an essential role in the early stages of endometriosis pathogenesis; and (3) targeting both of these drivers allows the marked suppression of ectopic lesion growth in animals compared with either individual agent alone. (Soyal et al., 2005) . All animal care was controlled by the ethical regulations approved by the Institutional Animal Care and Use Committee at Baylor College of Medicine.
Immortalized Human Endometrial Cells iHESCs and EMosis-CC/TERT1 (immortalized human endometriotic epithelial cells) were employed and confirmed by short tandem repeat profiling; these cells were not contaminated with mycoplasma.
Surgically Induced Endometriosis Endometriosis in mice was surgically induced under aseptic conditions under anesthesia. Details on surgically induced endometriosis are found in the Supplemental Experimental Procedures.
Generation of ERBAI and ERb:OE Mice
Details on these mice are found in the Supplemental Experimental Procedures.
In Vivo Analysis of Human Ectopic Lesion Growth in SCID Mice
The bioluminescence images of human ectopic lesions developed with iHESCs/Luc plus iHEECs/Luc (or iHEECs/ERb/Luc) in SCID mice were determined. Details on this are found in the Supplemental Experimental Procedures. For basic procedures, see the Supplemental Experimental Procedures.
Statistical Analyses
The data are expressed as the mean ± SD. Significance was assessed using an independent two-tailed Student's t test; A p value of less than 0.1 was considered statistically significant. NS, non-specific. *p < 0.1, **p < 0.01, ***p < 0.005 by Student's t test. 
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